Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
2031152-10-8
Purity
95%
XMU-MP-2 exhibited target-specific inhibition of BRK kinase activity and disrupted signaling pathways mediated by this activity, thereby reducing proliferation in BRK-positive breast cancer cells.
Properties
Name
XMU-MP-2
Smiles
CN1CN(CC=2C=NC(NC=3C=CC(=NC3)N4CCC(O)CC4)=NC12)C=5C=C(NC(=O)C=6C=CC=C(C6)C(F)(F)F)C=CC5C
Targets
Please log in to see this information
No records
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$85
2 mg
$85
5 mg
$164
10 mg
$283
15 mg
$POA
20 mg
$403
25 mg
$490
30 mg
$577
35 mg
$664
40 mg
$751
45 mg
$805
50 mg
$859
75 mg
$1142
100 mg
$POA
Quantity
1
Total amount
$ 164
No records
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.